SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-003496
Filing Date
2022-05-12
Accepted
2022-05-12 14:22:26
Documents
46
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q coeptis_i10q-033122.htm   iXBRL 10-Q 564664
2 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 coeptis_ex3101.htm EX-31.1 8480
3 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 coeptis_ex3102.htm EX-31.2 8660
4 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION coeptis_ex3201.htm EX-32.1 2735
5 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION coeptis_ex3202.htm EX-32.2 2745
  Complete submission text file 0001683168-22-003496.txt   2919635

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20220331.xsd EX-101.SCH 26882
7 XBRL CALCULATION FILE coep-20220331_cal.xml EX-101.CAL 39928
8 XBRL DEFINITION FILE coep-20220331_def.xml EX-101.DEF 97989
9 XBRL LABEL FILE coep-20220331_lab.xml EX-101.LAB 207485
10 XBRL PRESENTATION FILE coep-20220331_pre.xml EX-101.PRE 163940
40 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10q-033122_htm.xml XML 279473
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Filer) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56194 | Film No.: 22917187
SIC: 2834 Pharmaceutical Preparations